IN2014DN03005A - - Google Patents
Info
- Publication number
- IN2014DN03005A IN2014DN03005A IN3005DEN2014A IN2014DN03005A IN 2014DN03005 A IN2014DN03005 A IN 2014DN03005A IN 3005DEN2014 A IN3005DEN2014 A IN 3005DEN2014A IN 2014DN03005 A IN2014DN03005 A IN 2014DN03005A
- Authority
- IN
- India
- Prior art keywords
- protein
- acid sequences
- adenoviral
- adenovirus
- pertaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10333—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161543638P | 2011-10-05 | 2011-10-05 | |
| PCT/US2012/058956 WO2013052799A2 (en) | 2011-10-05 | 2012-10-05 | Adenoviral vectors and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN03005A true IN2014DN03005A (pl) | 2015-05-08 |
Family
ID=47045178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3005DEN2014 IN2014DN03005A (pl) | 2011-10-05 | 2012-10-05 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9233153B2 (pl) |
| EP (1) | EP2764012B1 (pl) |
| JP (2) | JP6757119B2 (pl) |
| CN (1) | CN103974969B (pl) |
| BR (1) | BR112014008167B1 (pl) |
| CA (1) | CA2850629C (pl) |
| IN (1) | IN2014DN03005A (pl) |
| WO (1) | WO2013052799A2 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6757120B2 (ja) | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| US9233153B2 (en) | 2011-10-05 | 2016-01-12 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| CN103987726B (zh) | 2011-10-05 | 2017-10-03 | 金维克有限公司 | 猴(大猩猩)腺病毒或腺病毒载体及其使用方法 |
| WO2013052859A2 (en) * | 2011-10-05 | 2013-04-11 | Genvec, Inc. | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine |
| HK1210475A1 (en) | 2012-05-29 | 2016-04-22 | Genvec, Inc. | Herpes simplex virus vaccine |
| BR112017026523A2 (pt) * | 2015-06-12 | 2018-08-14 | Glaxosmithkline Biologicals Sa | vetor recombinante, adenovírus recombinante, composição, uso de um vetor recombinante, de um adenovírus recombinante ou de uma composição, método para induzir uma resposta imune em um indivíduo, e, polinucleotídeo isolado. |
| EP3504230A1 (en) | 2016-08-23 | 2019-07-03 | GlaxoSmithKline Biologicals SA | Fusion peptides with antigens linked to short fragments of invariant chain (cd74) |
| WO2018060288A1 (en) | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| WO2018064523A1 (en) | 2016-09-30 | 2018-04-05 | Genvec, Inc. | Adenovectors for delivery of therapeutic genetic material into t cells |
| GB201616904D0 (en) | 2016-10-05 | 2016-11-16 | Glaxosmithkline Biologicals Sa | Vaccine |
| WO2018069316A2 (en) | 2016-10-10 | 2018-04-19 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
| ES2959811T3 (es) | 2016-12-09 | 2024-02-28 | Glaxosmithkline Biologicals Sa | Construcciones de adenovirus de chimpancé con antígenos de Lyssavirus |
| GB201701239D0 (en) | 2017-01-25 | 2017-03-08 | Glaxosmithkline Biologicals Sa | Novel formulation |
| ES2906441T3 (es) * | 2017-07-05 | 2022-04-18 | Nouscom Ag | Secuencias de ácidos nucleicos y de aminoácidos del adenovirus de los grandes simios no humanos, vectores que las contienen y usos de las mismas |
| WO2019016756A1 (en) | 2017-07-21 | 2019-01-24 | Glaxosmithkline Biologicals Sa | ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES |
| IL277128B2 (en) | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
| KR20250136930A (ko) | 2018-03-06 | 2025-09-16 | 프레시전 인코포레이티드 | 사람 파필로마바이러스 백신 및 이의 용도 |
| EP3587581A1 (en) | 2018-06-26 | 2020-01-01 | GlaxoSmithKline Biologicals S.A. | Formulations for simian adenoviral vectors having enhanced storage stability |
| KR20220076510A (ko) | 2019-10-08 | 2022-06-08 | 트러스티스 오브 보스톤 칼리지 | 다수의 서로 다른 비천연 아미노산을 함유하는 단백질 및 이러한 단백질의 제조 및 사용 방법 |
| CN115484978A (zh) | 2020-03-05 | 2022-12-16 | 尼奥克斯医疗有限公司 | 使用免疫细胞治疗癌症的方法和组合物 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
| SK282843B6 (sk) | 1993-07-13 | 2002-12-03 | Rhone-Poulenc Rorer S. A. | Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom |
| WO1995016772A1 (en) | 1993-12-14 | 1995-06-22 | Cornell Research Foundation, Inc. | Adenovirus gene expression system |
| US5851806A (en) | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
| ATE336587T1 (de) | 1994-06-10 | 2006-09-15 | Genvec Inc | Adenoviren-vektor systeme und zelllinien |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
| IL160406A0 (en) | 1995-06-15 | 2004-07-25 | Crucell Holland Bv | A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products |
| US5837511A (en) | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
| JP2000504223A (ja) | 1996-01-29 | 2000-04-11 | ジョージタウン・ユニヴァーシティ | Ｍｓａ１ペブチドの付加に基づいたマラリアワクチン |
| US6113913A (en) | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| AU2001234981A1 (en) * | 2000-02-09 | 2001-08-20 | Genvec, Inc. | Adenoviral capsid containing chimeric protein ix |
| US6821519B2 (en) | 2000-06-29 | 2004-11-23 | Corixa Corporation | Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| US20040136963A1 (en) | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| US6677156B2 (en) | 2001-07-23 | 2004-01-13 | Genvec, Inc. | Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| US6682929B2 (en) | 2001-07-23 | 2004-01-27 | Genvec, Inc. | Adenovector complementing cells |
| AU2002327380A1 (en) | 2001-07-23 | 2003-03-18 | Genvec, Inc. | Cells and methods for propagating adenoviral vectors |
| JP2005503797A (ja) | 2001-09-13 | 2005-02-10 | ジェンベク、インコーポレイティッド | アデノウイルスベクター及び関連する系、並びに製造及び使用の方法 |
| WO2005075506A1 (en) * | 2004-01-09 | 2005-08-18 | The Scripps Research Institute | Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors |
| US7851218B2 (en) * | 2004-12-13 | 2010-12-14 | Schering Corporation | Cell lines for production of replication-defective adenovirus |
| BRPI0615400A2 (pt) | 2005-08-31 | 2011-05-17 | Genvec Inc | vacinas para malária baseadas em vetor adenoviral |
| WO2007073513A2 (en) | 2005-11-10 | 2007-06-28 | Genvec, Inc. | Method for propagating adenoviral vectors encoding inhibitory gene products |
| CA2658484A1 (en) | 2006-07-20 | 2008-01-24 | Vical Incorporated | Compositions and methods for vaccinating against hsv-2 |
| WO2010051367A1 (en) | 2008-10-31 | 2010-05-06 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses sadv-43, -45,-48,-49, and -50 and uses thereof |
| PL2391638T3 (pl) * | 2009-02-02 | 2018-11-30 | Glaxosmithkline Biologicals Sa | Sekwencje nukleotydowe i aminokwasowe małpiego adenowirusa, zawierające je wektory i ich zastosowania |
| JP5903045B2 (ja) | 2009-07-31 | 2016-04-13 | パックスバックス， インコーポレイテッド | アデノウイルスに基づくベクター |
| KR20120139672A (ko) | 2009-11-09 | 2012-12-27 | 젠벡, 인코포레이티드 | 원숭이 아데노바이러스 벡터의 증식 방법 |
| US8450350B2 (en) | 2010-05-05 | 2013-05-28 | Infinity Pharmaceuticals, Inc. | Triazoles as inhibitors of fatty acid synthase |
| WO2012021730A2 (en) | 2010-08-11 | 2012-02-16 | Genvec, Inc. | Respiratory syncytial virus (rsv) vaccine |
| CN103987726B (zh) | 2011-10-05 | 2017-10-03 | 金维克有限公司 | 猴(大猩猩)腺病毒或腺病毒载体及其使用方法 |
| WO2013052859A2 (en) * | 2011-10-05 | 2013-04-11 | Genvec, Inc. | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine |
| JP6757120B2 (ja) * | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| US9233153B2 (en) | 2011-10-05 | 2016-01-12 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| WO2013116591A1 (en) * | 2012-02-02 | 2013-08-08 | Genvec, Inc. | Adenoviral vector-based malaria vaccine |
| HK1210475A1 (en) | 2012-05-29 | 2016-04-22 | Genvec, Inc. | Herpes simplex virus vaccine |
-
2012
- 2012-10-05 US US14/349,421 patent/US9233153B2/en active Active
- 2012-10-05 EP EP12775110.5A patent/EP2764012B1/en active Active
- 2012-10-05 CN CN201280059666.3A patent/CN103974969B/zh active Active
- 2012-10-05 JP JP2014534767A patent/JP6757119B2/ja active Active
- 2012-10-05 CA CA2850629A patent/CA2850629C/en active Active
- 2012-10-05 BR BR112014008167-0A patent/BR112014008167B1/pt active IP Right Grant
- 2012-10-05 IN IN3005DEN2014 patent/IN2014DN03005A/en unknown
- 2012-10-05 WO PCT/US2012/058956 patent/WO2013052799A2/en not_active Ceased
-
2016
- 2016-01-11 US US14/992,152 patent/US9725738B2/en active Active
-
2017
- 2017-07-14 US US15/650,289 patent/US10260074B2/en active Active
-
2018
- 2018-07-20 JP JP2018137235A patent/JP6970059B2/ja active Active
-
2019
- 2019-02-22 US US16/282,924 patent/US11034975B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10260074B2 (en) | 2019-04-16 |
| CN103974969B (zh) | 2018-06-29 |
| BR112014008167A2 (pt) | 2017-04-11 |
| JP6757119B2 (ja) | 2020-09-16 |
| US20140248307A1 (en) | 2014-09-04 |
| WO2013052799A3 (en) | 2013-07-04 |
| JP2018198602A (ja) | 2018-12-20 |
| BR112014008167B1 (pt) | 2022-05-24 |
| JP2014530604A (ja) | 2014-11-20 |
| US20160122781A1 (en) | 2016-05-05 |
| CA2850629A1 (en) | 2013-04-11 |
| CN103974969A (zh) | 2014-08-06 |
| US11034975B2 (en) | 2021-06-15 |
| US9233153B2 (en) | 2016-01-12 |
| EP2764012A2 (en) | 2014-08-13 |
| CA2850629C (en) | 2024-05-21 |
| US20190316152A1 (en) | 2019-10-17 |
| WO2013052799A2 (en) | 2013-04-11 |
| EP2764012B1 (en) | 2022-02-23 |
| US9725738B2 (en) | 2017-08-08 |
| US20180066281A1 (en) | 2018-03-08 |
| JP6970059B2 (ja) | 2021-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN03061A (pl) | ||
| IN2014DN03005A (pl) | ||
| WO2013052832A3 (en) | Simian (gorilla) adenovirus or adenoviral vectors and methods of use | |
| IL241494A0 (en) | Simian adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof | |
| IL219882A0 (en) | System for increasing gene expression and vector comprising the system | |
| SG11201403450VA (en) | Artificial nucleic acid molecules for improved protein or peptide expression | |
| PH12012500908A1 (en) | Methods of propagating monkey adenoviral vectors | |
| EP3137120A4 (en) | In vivo gene engineering with adenoviral vectors | |
| AU2011356210A8 (en) | Novel fucosyltransferases and their applications | |
| EP2582397A4 (en) | COMPOUNDS AND METHOD FOR MODULATING INTERACTION BETWEEN PROTEINS AND TARGET NUCLEIC ACIDS | |
| ZA201309016B (en) | Simian adenovirus and hybrid adenoviral vectors | |
| WO2012027572A3 (en) | Methods for nucleic acid capture and sequencing | |
| IL228328B (en) | Aav vectors without capsid, preparations and methods for vector preparation and gene transfer | |
| WO2013052859A3 (en) | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine | |
| HUE037926T2 (hu) | Nukleinsav konjugátumok számára endoszomolitikus szereket tartalmazó, optimalizált in vivo szállítórendszer | |
| IT1395511B1 (it) | Apparato per riscaldamento con microonde di prodotti planari | |
| WO2013119302A3 (en) | Gh61 polypeptide variants and polynucleotides encoding same | |
| EP2592944A4 (en) | BEVERAGES WITH HIGH PROTEIN CONTENT AND WHEY PROTEINS | |
| EP2138580A4 (en) | VECTOR FOR GENE THERAPY | |
| PL3461888T3 (pl) | Ulegające zużyciu krioprezerwowane komórki wykazujące przejściową nadekspresję genu(-ów) kodującego(-ych) białko(-a) transportera leku i/lub enzym(y) metabolizujący(-e) lek | |
| WO2017041063A3 (en) | Compositions and methods for identifying genetic predisposition to obesity and for enhancing adipogenesis | |
| PL2681532T3 (pl) | Wyznaczanie DNA i/lub RNA na podstawie danych ze spektrofotometru UV-VIS | |
| SG10201505354PA (en) | Dna element having the activity of enhancing foreign gene expression | |
| GB201004143D0 (en) | Promoter sequence for DNA and viral vectors | |
| WO2009143277A3 (en) | Compositions comprising hscn9a sirna and methods of use thereof |